Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01796197 |
Title | Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Brigham and Women's Hospital | Boston | Massachusetts | 02215 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details |